AffiliationUrological Oncology, The Christie Hospital NHS Foundation Trust, Wilmslow Road, M20 4BX, Manchester, England.
MetadataShow full item record
AbstractOver the course of the past 30 years progress in identification of risk factors, improvements in therapy regimens and advances in treatment delivery have all served to render testis cancer a treatable and survivable malignancy. Institution of specialised oncology centres in the UK to address treatment options for urological cancers has proven to be an effective approach to managing testis cancer by drawing on interdisciplinary expertise and applying insights gained from ongoing R&D. This strategy could become a model for treating other cancers as well.
CitationTestis cancer: the UK as a model., 2009, 48 (4):386-92 Urologe A
JournalDer Urologe. Ausg. A
- A medical oncologist's perspective on the treatment of patients with genitourinary malignancies.
- Authors: Sternberg CN
- Issue date: 2009 Mar-Apr
- Urological oncology in Europe. Research highlights from the XVIIth congress of the European Association of Urology, Birmingham, UK, February 23-26, 2002.
- Authors: Thompson E
- Issue date: 2002 Apr
- Future development of penile cancer services in the UK.
- Authors: Singh R, James ND, Watkin NA
- Issue date: 2004 Nov
- [The "German Testicular Cancer Study Group" (GTCSG) as an example of successful interdisciplinary cooperation].
- Authors: Heidenreich A, Krege S
- Issue date: 2007 Sep
- Advances in our understanding of the biology, new diagnostic approaches and recent treatment strategies for testicular germ cell cancer.
- Authors: Kuczyk M, Bokemeyer C, Hartmann JT
- Issue date: 2004 Apr